Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Response to Laryngoscopy in Hypertensive Patients
NCT07557680Phase 3Completed
- Sponsor
- Sindh Institute of Urology and Transplantation
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in hypertension (HTN), sponsored by Sindh Institute of Urology and Transplantation. Started Jan 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07557680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07557680.